[
    {
        "subject": "Accumulation of MDSCs associated with tumor growth",
        "link": "could be because of",
        "object": "various mechanisms"
    },
    {
        "subject": "Various mechanisms",
        "link": "include",
        "object": "presence of excessive growth factors, cytokines, or inflammatory molecules"
    },
    {
        "subject": "Presence of excessive growth factors, cytokines, or inflammatory molecules",
        "link": "provide",
        "object": "continuous survival signals"
    },
    {
        "subject": "Absence of signals",
        "link": "normally induce cell death",
        "object": "or"
    },
    {
        "subject": "Nonresponsiveness of MDSCs to death signals",
        "link": "is",
        "object": "another mechanism"
    },
    {
        "subject": "Mass spectrometry screen of MDSCs",
        "link": "observed expression of multiple proteins associated with",
        "object": "Fas-FasL (Fas ligand) apoptosis pathway"
    },
    {
        "subject": "MDSCs",
        "link": "express",
        "object": "death receptor Fas"
    },
    {
        "subject": "MDSCs",
        "link": "are killed when",
        "object": "Fas is engaged by FasL"
    },
    {
        "subject": "Activated T cells expressing FasL",
        "link": "mediate apoptosis of MDSCs in vivo",
        "object": "suggesting that Fas-FasL interactions may regulate MDSC homeostasis"
    },
    {
        "subject": "Fas-FasL interactions",
        "link": "could be exploited as a strategy to",
        "object": "reduce MDSC levels in vivo"
    }
]